Jun 20, 2024, 07:10 AM by

Jun 19, 2024, 05:00 AM by User Not Found

Bio-IT World | Artificial intelligence (AI) was the main topic at the 2024 Bio-IT World Conference & Expo. While there was much excitement over new developments, there were also many discussions covering the obstacles that block the path to further progress—many of which have nothing to do with technology or data.

Jun 18, 2024, 07:47 AM by

Instem, a leading provider of IT solutions and services to the global life sciences market, has partnered with Proscia®, a global leader in AI-enhanced pathology solutions for precision medicine.

Jun 18, 2024, 07:47 AM by

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024

Jun 18, 2024, 05:00 AM by User Not Found

Bio-IT World | AlphaFold was revolutionary to protein scientists and their work, but as soon as the new capabilities became clear, scientific demand exploded. Regeneron engineers used the AlphaFold2 model to create a custom, cloud-based solution to allow analysis of thousands of protein binding partners in parallel.

Jun 14, 2024, 07:16 AM by

ProPharma, the world’s largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award.

Jun 14, 2024, 07:16 AM by

Jun 13, 2024, 08:54 AM by

Please see latest news from Qlucore who has signed an agreement with Uppsala University Hospital. The Hospital will use the Qlucore Insights software to improve the analysis of acute lymphoblastic leukemia (ALL) in children. Please get in touch if you require further information.

Jun 13, 2024, 08:54 AM by

Jun 13, 2024, 08:54 AM by

Small molecule specialists Onyx Scientific has made a significant new addition to its commercial team with the appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.

Jun 13, 2024, 08:54 AM by

A new survey by Phreesia, in partnership with the National Kidney Foundation, finds that discussions between patients and providers, and patient activation, are key to helping high-risk patients take preventive actions to manage their kidney health.

Jun 13, 2024, 08:54 AM by

Mage Biologics (“Mage”) announces it has dosed the first study participant in a first-in-human study of MB-001, a best-in-class orally administered antibody designed for the treatment of inflammatory bowel disease (IBD).

Jun 13, 2024, 05:00 AM by User Not Found

Bio-IT World | Data is a double-edged sword in the industry. It is a necessary tool for technological developments, especially artificial intelligence (AI), but the excess generation of data has become a thorn on the sides of researchers and companies. And for universities, they have their own sets of problems to deal with.

Jun 12, 2024, 07:18 AM by

Integrated DNA Technologies today launched the Avian Influenza Type A (H5) Primers and Probe Set to enable researchers to identify, target, and trace the presence of clade 2.3.4.4b of the H5N1 virus across bird, environmental, dairy cow, and poultry farm samples.

Jun 12, 2024, 07:18 AM by

CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’ CluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials

Jun 12, 2024, 07:18 AM by

CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT

Jun 12, 2024, 05:00 AM by User Not Found

Bio-IT World | When it comes to big data, the largest amount comes from whole genome sequencing (WGS). At the population scale, WGS produces petabytes of information that for sharing purposes requires cloud computing capabilities. That realization came early to UK Biobank.

Jun 11, 2024, 10:48 AM by

Exothera has announced that Asgard Therapeutics has selected them to develop and scale-up a manufacturing process for the viral vector-based immunotherapy candidate AT-108, including development of analytical methods, GMP-grade material production, and aseptic filling.

Jun 11, 2024, 05:00 AM by User Not Found

Bio-IT World | At COMPUTEX Taipei earlier this month, NVIDIA launched NIM—NVIDIA Inference Microservices—a simple, standardized way to add generative AI to applications. Data generation—rather than retrieval—is poised to take over computing.

Jun 7, 2024, 08:08 AM by